OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study
Adam Nowiński, S Wesółowski, Maria Korzeniewska-Koseła
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 15

Showing 15 citing articles:

Determinants of Tuberculosis Mortality in an Urban Residents: A hospital-based Cohort Study in China
S. Ruan, Z.Y. Liu, Zhi Mao, et al.
Clinical Epidemiology and Global Health (2025), pp. 101934-101934
Open Access

Advances in spray drying technology for anti-tubercular formulation development: A comprehensive review
Eknath Kole, Krishna Jadhav, Yogesh A. Sonar, et al.
Drying Technology (2025), pp. 1-37
Closed Access

Knowledge and Prevalence of Latent Tuberculosis Infection: A Feasibility and Pilot Study in a Primary Healthcare Setting in Rural Eastern Cape, South Africa
Cebo Magwaza, Oluwakemi Laguda-Akingba, Teke Apalata, et al.
International Journal of Environmental Research and Public Health (2025) Vol. 22, Iss. 3, pp. 320-320
Open Access

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic
Zijian Wang, Sheng Zhao, Aiping Zhang, et al.
Tuberculosis (2024) Vol. 146, pp. 102499-102499
Open Access | Times Cited: 3

Identification and evaluation of drug related problems to first line therapy of antitubercular drugs among the pulmonary tuberculosis patients in a tertiary care hospital- A Randomised controlled study
Bandaru Yeswanth Raja, Madiwalayya Shivakantayya Ganachari
International Journal of Pharmaceutical Sciences and Drug Research (2024), pp. 142-148
Open Access | Times Cited: 2

PPARdelta: A key modulator in the pathogenesis of diabetes mellitus and Mycobacterium tuberculosis co-morbidity
Halemah AlSaeed, Mohammed Haider, Fawaz Alzaïd, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110046-110046
Open Access | Times Cited: 1

A Comparative Investigation on Cytokine Expression in Pulmonary Tuberculosis and Comorbidity with Type 2 Diabetes Mellitus
Khusbu Singh, Tahziba Hussain, Bhawna Gupta, et al.
International Journal of Mycobacteriology (2024) Vol. 13, Iss. 2, pp. 165-170
Open Access | Times Cited: 1

Non-communicable comorbidities in pulmonary tuberculosis and healthcare utilization: a cross-sectional study of 2021 Indonesian national health insurance data
Danik Iga Prasiska, Durga Datta Chapagain, Kennedy Mensah Osei, et al.
Archives of Public Health (2024) Vol. 82, Iss. 1
Open Access | Times Cited: 1

The influence of comorbidities on treatment outcomes in patients with tuberculosis
Diana Ivanova, Evgeny Belilovskiy, E. M. Bogorodskaya, et al.
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 8, pp. 790-796
Open Access | Times Cited: 1

Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review
William J. Burman, Pauline Luczynski, C. Robert Horsburgh, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 1

Tuberculosis treatment outcomes and associated factors: A retrospective study in West Nusa Tenggara, Indonesia
Meiyanti Meiyanti, Adang Bachtiar, Rina K. Kusumaratna, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e1660-e1660
Closed Access

Page 1

Scroll to top